Biotech & Life Sciences

Novo Holdings had a rough 2025, and its CEO is not pretending otherwise. The Copenhagen-based investment company — which controls the wealth behind Novo Nordisk and the Novo Nordisk Foundation — saw assets under management fall roughly 35% last year, from EUR 142 billion to EUR 93 billion.

Idorsia is back on the CEO carousel — and this time, the founder is driving. The Swiss biotech announced March 16 that Dr.

Researchers at VIB-KU Leuven and the Francis Crick Institute found that breast cancer metastases reprogram healthy lung cells to produce lipids — and that blocking this supply slows tumor growth. The mechanism reframes lipids from fuel source to signaling molecule.

At a STAT Summit, researchers and pharma executives debated whether China's accelerating cell and gene therapy sector represents a competitive crisis for American biotech or simply a new reality to partner with — and the answer reveals deep disagreements about what leadership actually means.

Baylor became the first early-access customer for Nautilus' Voyager proteomics platform, deploying it on an NIH-funded cancer project to connect isoform-level protein data with multiomics pipelines — a test of whether the technology can move from demos to operational oncology research.

Bill Gates nuclear company is making a play for the radiopharmaceutical supply chain. TerraPower Isotopes announced March 17 that it will invest $450 million to build a 250,000-square-foot actinium-225 manufacturing facility in the Bellwether District of Philadelphia — a redevelopment of the for...

Verily is finally on its own. The health tech company, which has been part of Alphabet since it was spun out of Google in 2015, said Thursday it has raised $300 million in new outside funding that ends Alphabet's controlling position.

University of Utah researchers found that malaria parasites run spinning iron crystals powered by hydrogen peroxide breakdown — the same chemistry used to launch rockets — and it may be a drug target the field has overlooked for decades.

Nature Medicine research shows blood sugar can return to normal through fat redistribution alone — without weight loss — offering the same protection against future diabetes.

Basecamp Research, with Anthropic, Ultima Genomics, and PacBio, is building a 100-million-species genomic dataset to train AI models that learn from evolution rather than from existing clinical data.

Lawmakers Signal They'll Act on China's Grip on America's Drug Supply The House Select Committee on the Chinese Communist Party held a hearing Wednesday on what lawmakers of both parties have increasingly called a national security vulnerability: the United States' dependence on China for the bu...